BioNTech SE
BNTX
$92.80
-$0.87-0.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.94B | -1.44B | -1.26B | -633.26M | -381.92M |
| Total Depreciation and Amortization | 550.11M | 304.22M | 210.06M | 273.71M | 177.32M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 945.62M | 935.71M | 1.04B | -32.19M | -306.93M |
| Change in Net Operating Assets | 1.24B | 1.15B | 628.56M | 155.31M | -1.34B |
| Cash from Operations | 801.87M | 956.15M | 617.72M | -236.43M | -1.85B |
| Capital Expenditure | -243.05M | -211.48M | -197.76M | -195.18M | -233.24M |
| Sale of Property, Plant, and Equipment | 9.81M | 6.49M | 5.18M | 5.23M | 2.17M |
| Cash Acquisitions | 308.25M | 308.25M | 225.64M | -82.61M | -82.61M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.40B | -1.39B | -3.05B | 1.08B | 2.04B |
| Cash from Investing | -1.33B | -1.29B | -3.02B | 803.92M | 1.73B |
| Total Debt Issued | 82.90M | 45.10M | 6.70M | -- | -- |
| Total Debt Repaid | -59.60M | -55.80M | -57.60M | -45.90M | -42.30M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -129.20M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.00M | -2.00M | -2.00M | -- | -- |
| Cash from Financing | -123.65M | -14.89M | -59.71M | -50.84M | -46.08M |
| Foreign Exchange rate Adjustments | -31.18M | -16.97M | -30.01M | -17.14M | 5.47M |
| Miscellaneous Cash Flow Adjustments | 31.06M | 35.13M | 8.16M | -18.45M | 23.37M |
| Net Change in Cash | -649.01M | -326.51M | -2.48B | 481.05M | -139.33M |